Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Hereditary Cancer Testing Market Grown from 2024 to 2025?

The market size of hereditary cancer testing has seen a quick expansion in recent years. An increase from $4.32 billion in 2024 to $4.78 billion in 2025 is expected, at a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth in the historic period include an increase in hereditary cancers, genetic counseling initiatives, government cancer prevention programs, better insurance coverage, comprehension of gene-environment interactions, along with patient advocacy and support groups.

What Growth Rate Is Anticipated for the Hereditary Cancer Testing Market in the Coming Years?

Rapid expansion is anticipated in the hereditary cancer testing market in the coming years, growing to a substantial $7.37 billion in 2029, at a compound annual growth rate (CAGR) of 11.4%. This surge in the predicted period is due to the development of targeted therapies, improvements in precision medicine, an increase in consumer-direct testing, worldwide health initiatives, and advancements in bioinformatics. During the forecast period, significant trends would include the evolution of genetic sequencing technologies, the rise of telemedicine, remote genetic counseling, precision medicine, personalized treatments, cancer risk evaluation models, and legal and ethical considerations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp

Who Are the Leading Companies in the Hereditary Cancer Testing Market?

Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

What Are the Key Drivers of the Hereditary Cancer Testing Market?

The rise in hereditary cancer incidence is anticipated to stimulate the growth of the hereditary cancer testing market. Hereditary cancer syndromes are caused by specific gene mutations inherited from parents to offspring. Hereditary cancer testing is capable of identifying these inheritable, disease-related gene mutations, providing an in-depth risk evaluation of cancer for patients. For example, a BioMed Central article on hereditary cancer in clinical practice, published in June 2022, reveals that approximately 10% of pancreatic cancer incidences are genetically related. Consequently, the escalating incidence of hereditary cancer propels the expansion of the hereditary cancer testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp

What Are the Key Market Segments in the Hereditary Cancer Testing Industry?

The hereditary cancer testing market covered in this report is segmented –

1) By Test Type: Multi Panel Test, Single-Site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

Subsegments:

1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels

2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing

What Are the Latest Trends in the Hereditary Cancer Testing Market?

The upswing in technological innovation is a primary trend sweeping the hereditary cancer testing market. With a view to maintaining their standing in the marketplace, chief players are centered on technological advancements. As a case in point, Myriad Genetics, an American genetic testing and precision medicine firm, in March 2022, rolled out genetic testing with a Polygenic Breast Cancer Risk Assessment Score applicable to all ancestries. Their MyRisk Hereditary Cancer test with RiskScore provides a customized risk estimate for breast cancer to all women, irrespective of their genetic origin, who have not been previously diagnosed with breast cancer.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

What Are the Key Regional Markets in the Hereditary Cancer Testing Industry?

North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121

This Report Delivers Insight On:

1. How big is the hereditary cancer testing market, and how is it changing globally?

2. Who are the major companies in the hereditary cancer testing market, and how are they performing?

3. What are the key opportunities and risks in the hereditary cancer testing market right now?

4. Which products or customer segments are growing the most in the hereditary cancer testing market?

5. What factors are helping or slowing down the growth of the hereditary cancer testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model